Amitava Mitra

5PUBLICATIONS
14CO-AUTHORS
PharmacogenomicsNanomedicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 02, 2026
A Practical Alternative to Refine the Estimate of fmCYP3A4 and Evaluate Drug-Drug Interaction Potential for Ziftomenib Using PBPK Modeling to Inform Labeling.

|May 04, 2026
Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation.

|Mar 25, 2026
Farnesyl Transferase Inhibitor KO-2806 (Darlifarnib) Enhances the Antitumor Activity of Tyrosine Kinase Inhibitors in RCC.

Jovylyn G Gasendo, Stacia Chan, Hetika V Patel

|Mar 19, 2026
Model-Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC: A QSP Model for Alpelisib and Tipifarnib Combination.

Jaehee Shim, Douglas Chung, Alison Smith

|Feb 09, 2026
The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition.

Hetika Vora Patel, Alison Elizabeth Smith, Stacia Chan

Pageof 1

Frequent Collaborators

2 joint publications

Hetika Vora Patel

2 joint publications

Alison Elizabeth Smith

2 joint publications

Stacia Chan

2 joint publications

Jovylyn Gatchalian Gasendo